A case of convulsion: Brugada syndrome

Similar documents
A case of Brugada syndrome coexisting with vasospastic angina: Caution should be taken when using calcium channel blockers

CME Article Brugada pattern masking anterior myocardial infarction

P. Brugada 1, R. Brugada 2 and J. Brugada 3. Introduction. U.S.A.; 3 Unitat d Arritmias, Hospital Clinic, Barcelona, Spain

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

How agressively should we treat asymptomatic patients with Brugada syndrome. Josep Brugada Medical Director Hospital Clínic, University of Barcelona

A 19 Year old Woman Admitted to Hospital Confused and Agitated with Intermittent Twitching of her Upper and Lower Limbs

ICD in a young patient with syncope

M Furuhashi, K Uno, K Tsuchihashi, D Nagahara, M Hyakukoku, T Ohtomo, S Satoh, T Nishimiya, K Shimamoto

The Brugada Syndrome: An Easily Identified and Preventable Cause of Sudden Cardiac Death

Are there low risk patients in Brugada syndrome?

An Approach to the Patient with Syncope. Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva

Case Report. Faculty of Medicine, Oita University 2 Department of Cardiology, Hakuaikai Hospital

Optimal management of Brugada syndrome

Approximately 5% of patients who experience sudden death

Sudden cardiac death: Primary and secondary prevention

Clinical profile and genetic basis of Brugada syndrome in the Chinese population

MICS OF MYOCARDIAL ISCHEMIA AND INFARCTION REVISED FOR LAS VEGAS

Brugada Syndrome: Age is just a number

Ripolarizzazione precoce.

When the rhythm of life is disturbed

Solutions for Every Day Problems Cardiologists and the ECG: Are We Really That Good at It? Part II Daniel José Piñeiro Profesor Titular de Medicina,

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Risk Stratification for Asymptomatic Patients With Brugada Syndrome

The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol

Masqueraders of STEMI

The Electrophysiologic Mechanism of ST-Segment Elevation in Brugada Syndrome

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

Ventricular tachycardia Ventricular fibrillation and ICD

Brugada syndrome is a cardiac disease caused by an

Remote Monitoring & the Smart Home of the 21 Century

Supplementary Online Content

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

Electrophysiologic investigation in Brugada syndrome

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Secondary prevention of sudden cardiac death

Atrial fibrillation (AF) is a disorder seen

Case Presentation. Asaad Khan University College Hospital Galway Rep of Ireland

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Acute Coronary Syndromes Unstable Angina Non ST segment Elevation MI (NSTEMI) ST segment Elevation MI (STEMI)

Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada

Invasive Risk Stratification: When is it needed?

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Pause-induced Ventricular Tachycardia: Clinical Characteristics

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

Apical Hypertrophic Cardiomyopathy With Hemodynamically Unstable Ventricular Arrhythmia Atypical Presentation

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?

FANS Paediatric Pathway for Inherited Arrhythmias*

Ripolarizzazione precoce. Non così innocente come si pensava

Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome

Diploma in Electrocardiography

Low Prevalence of Risk Markers in Cases of Sudden Death Due to Brugada Syndrome

Name of Presenter: Marwan Refaat, MD

Arrhythmias Focused Review. Who Needs An ICD?

Investigating the family after a sudden cardiac death. Dr Catherine Mercer Consultant Clinical Geneticist, Wessex

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

What Every Physician Should Know:

Ventricular Arrhythmia Induced by Sodium Channel Blocker in Patients With Brugada Syndrome

Case Report Accelerated Idioventricular Rhythm During Ajmaline Test: a Case Report

Heart Rhythm Disorders. How do you quantify risk?

ECG Cases and Questions. Ashish Sadhu, MD, FHRS, FACC Electrophysiology/Cardiology

Brugada syndrome presents in a certain number of

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

2/1/2013. Poisoning pitfalls. The original pitfall

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Ripolarizzazione precoce. Torino, 24th October Non così innocente come si pensava

Silvia G Priori MD PhD

Short QT Syndrome: Pharmacological Treatment

Intraoperative and Postoperative Arrhythmias: Diagnosis and Treatment

J Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs

Approximately 5% of patients who experience sudden

Unusual Tachycardia Association In A patient Without Structural Heart Disease

Pearls of the ESC/ERS Guidelines 2015 Channelopathies

Urgent VT Ablation in a Patient with Presumed ARVC

InterQual Care Planning SIM plus Criteria 2014 Clinical Revisions

SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM

Cardiac arrhythmias. Janusz Witowski. Department of Pathophysiology Poznan University of Medical Sciences. J. Witowski

Type 1 electrocardiographic burden is increased in symptomatic patients with Brugada syndrome

APPROACH TO TACHYARRYTHMIAS

FANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers)

Augmented ST-Segment Elevation During Recovery From Exercise Predicts Cardiac Events in Patients With Brugada Syndrome

Management of Syncope in Heart Failure. University of Iowa

Case Discussion. Date: 2011/03/12 Reporter: FM R1 宋泓逸 Supervisor: F1 許瓅文

Implantable cardioverter defibrillator, Inappropriate shock, Lead failure

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes

J-wave syndromes: update on ventricular fibrillation mechanisms

Ventricular Tachycardia Associated Syncope in a Patient of Variant Angina without Chest Pain

Signal-Averaged Electrocardiography (SAECG)

EHRA Accreditation Exam - Sample MCQs Invasive cardiac electrophysiology

Brugada syndrome: a review of the literature

Tachycardias II. Štěpán Havránek

Prediction of Life-Threatening Arrhythmia in Patients after Myocardial Infarction by Late Potentials, Ejection Fraction and Holter Monitoring

Case Report A Case of Isolated Left Ventricular Noncompaction with Basal ECG-Tracing Strongly Suggestive for Type-2 Brugada Syndrome

J Wave Syndrome: Clinical Diagnosis, Risk Stratification And Treatment Kamal K Sethi,Kabir Sethi,Surendra K Chutani

Transcription:

Hong Kong Journal of Emergency Medicine A case of convulsion: Brugada syndrome CK Shum, ML Tse, FL Lau, WK Chan A healthy 28-year-old man presented with multiple brief episodes of convulsion. He was found to have ventricular fibrillation which required defibrillation in the emergency department. After exclusion of organic heart diseases, Brugada syndrome was diagnosed and required implantable cardioverter defibrillator (ICD) implantation. The case emphasized the recognition of malignant cardiac dysrrhythmias as a cause for seizures. The management in the emergency department was discussed. (Hong Kong j.emerg.med. 2002;9:105-109) Keywords: Brugada syndrome, idiopathic ventricular fibrillation, seizure Case A 28-year-old man was reported to be semiconscious and had a convulsion lasting 1 minute. Ambulance staff arrived and witnessed another generalised convulsion lasting less than 1 minute. On arrival at the Accident and Emergency department, he was fully conscious. His vital signs were stable. He had retrograde amnesic and could not remember how he was sent to the hospital. Examination of the chest and heart were normal. Neurological examination was unremarkable. Abdominal examination was normal. He was put on cardiac monitoring in the resuscitation room. ECG (at 23:50) showed sinus rhythm, RBBB, ST elevation in V1-V2, the QTc 0.408 sec and the axis is 70 deg. (Figure 1) Correspondence to: Shum Kin, Cynthia, MBBS(HK), MRCS(A&E) United Christian Hospital, Accident and Emergency Department, 130 Hip Wo Street, Kowloon, Hong Kong Email: kshum@hkstar.com Tse Man Li, MBChB(CUHK), MRCP, FHKAM(Emergency Medicine) Lau Fei Lung, MRCP(UK), FRCS(A&E Ed), Dip. of Epidem. & App. Stat Chan Wai Kwong, FRCP(Lond), FRCP(Edin), FRCP(Glasg) Blood investigations included arterial blood gas which was normal with no metabolic or electrolyte disturbances. Chest X-ray performed showed normal cardiothoracic ratio. Cardiac monitor initially showed occasional polymorphic ventricular ectopics which later changed to ventricular fibrillation (VF), as documented in Figure 2. During the VF, he had starring eyes and tonic twitching of limbs with loss of consciousness. Defibrillation with 200J was required to return his rhythm to sinus. A repeat ECG showed a RBBB pattern with persistent ST elevation V1 to V2. His past health, family and medication history were unremarkable. Patient was admitted to Coronary Care Unit (CCU) for investigation of his cardiac syncope. The RBBB and ST elevation in V1 to V2 were the only peculiar findings in his ECG. Blood tests performed in CCU were all normal. Toxicology screening and viral study for myocarditis were negative. Echocardiogram revealed a normal heart with no structural abnormalities and good left and right ventricular ejection fractions. Cardiac

106 Hong Kong j. emerg. med. Vol. 9(2) Apr 2002 Figure 1. Initial ECG. Figure 2. Ventricular fibrillation as documented on cardiac monitor. catheterisation showed normal study. An Electrophysiological study performance (EPS) revealed inducible VF that required defibrillation to restore sinus rhythm. The flecainide test was used to unmask Brugada syndrome. Patient had ICD implantation and discharged home. His brothers and sisters were informed of the diagnosis. Since the inheritance is autosomal dominant they were invited to undergo screening. Such a screening is essential to make a diagnosis of Brugada syndrome and could potentially prevent them from dying of dysrrhythmias. Discussions This patient presented with recurrent 'convulsion' initially. There are many causes for such a presentation. History, physical examination and ECG constitute the core of the workup for patients presenting with syncope (combined diagnostic yield, 50%). These will provide a diagnosis or determine whether diagnostic testing is necessary in most patients. In subjects in whom heart disease is suspected or known, further cardiac testing, including echocardiography, stress testing, Holter monitoring or intracardiac electrophysiologic studies (diagnostic yield 5% to 35%) may be necessary. 2 This patient was put on cardiac monitoring and was closely observed in the resuscitation room. His ventricular fibrillation rhythm was revealed to be the cause of his myotonic twitching of the limbs and transient loss of consciousness. Close monitoring is a useful way to elucidate cardiac dysrrhythmias. Even though such rhythms may not appear during patient's stay at the Emergency Department but certainly there is a need to look out for them.

Shum et al./brugada syndrome 107 Electrolytes, glucose levels and toxic causes should be screened at the Emergency Department. They can also cause both neurologic and cardiac symptoms. The final diagnosis of Brugada syndrome turned out to be an increasingly recognised dysrrhythmic functional cardiac disease that emergency physicians should be aware of. This syndrome is in fact not uncommon in Hong Kong. Brugada syndrome Historical discovery of the syndrome ECG pattern of RBBB with ST elevation in leads V1 to V3 were found to associate with sudden death. In 1992, Brugada and Brugada were the first to speculate the syndrome to be a distinct clinical and ECG syndrome of functional cardiac origin. 3 The notion was further substantiated by the recognition that ECG abnormalities were that inconsistently present and altered autonomic tone and antiarrhythmic drugs modulate the extent of ST-segment elevation. 4 Diagnostic criteria for the syndrome includes: 1. > or = 0.1mV ST-segment elevation in leads V1, V2 and V3 (Refer to patient's initial ECG) 2. absence of organic heart disease (absence of ischemia, electrolyte or metabolic disorders, pulmonary or inflammatory diseases or abnormalities of central or peripheral nervous system.) 3. dynamic nature of the ST segment, both spontaneously in time and under the influence of pharmacological agents (Sodium channel blockers and autonomic modulators) 4. malignant family history in the case of an asymptomatic individual. 3 Other ECG features suggesting of the syndrome: 7 ST-segment elevations were designated either as coved or saddleback. (Figure 3) It is not unique or highly specific for the Brugada Syndrome and can be found in a variety of clinical settings. (Table 1) Diagnosis and management In many patients with the syndrome, the ECG manifestations may show dynamic changes or transiently normalize, leading to underdiagnosis of the syndrome. Sodium channel blockers (procainamide, ajmalin, or flecainide in therapeutic dosages) can unmask the ST segment elevation in many patients with concealed or intermittent forms of the syndrome with high sensitivity and specificity. 9 Electrophysiological study (EPS) with sodium channel blockers challenge in asymptomatic family members are recommended. The occurrence of > or = 0.1mV ST-segment elevation in leads V1, V2, and V3 is regarded as a positive response. In the case of inducible VF, an ICD is the only effective treatment. In asymptomatic individuals with a malignant family history, the threshold for ICD implantation should be low, regardless of electrophysiology results. 5 Prevalence of the Brugada syndrome In Japan, the prevalence of ECGs compatible with the syndrome is 0.05%. 6 The typical coved pattern of the Brugada syndrome (0.1%) was found in Europe. This foresees a major public health problem. Eighty percent of these patients could have inducible ventricular arrhythmias and ICD is the only effective treatment. 7 It was reported a 0.05% prevalence of the typical coved pattern 8 While a more recent study prevalence of saddleback ST-segment elevation (6%) and to typical coved ST-segment elevation (0.1%). 7 The Hermida et al study 7 did not find an increased mortality with a midterm follow-up. Sensitisation by a sodium channel blocker test could be proposed in the healthy population but needs to be further evaluated. Prophylatic ICD is the issue being further investigated. Since the first local case was reported in April 1999, there were over 30 patients in Hong Kong identified with Brugada syndrome by end of 2000. Preliminary data showed a male predominance, one third had either cardiac arrest or inducible polymorphic VT/VF. 10

108 Hong Kong j. emerg. med. Vol. 9(2) Apr 2002 Coved ST-segment elevation. Saddleback ST-segment elevations. Figure 3. ECG features that are suggestive of Brugada syndrome. Table 1. Differential diagnosis of ST segment elevation in Right Precordial Leads. 11 Arrhythmogenic RV dysplasia Right or left bundle branch block Left ventricular hypertrophy Left ventricular aneurysm Acute myocarditis Right ventricular infarction Pulmonary embolism Hyperkalaemia Hypercalcaemia Various central and autonomic nervous system abnormalities Friedreich ataxia Duchenne muscular dystrophy Thiamine deficiency Cocaine intoxication References 1. Lempert T. Recognizing syncope: pitfalls and surprises. J R Soc of Med 1996;89(7):372-5. 2. Linzer, M, Yang EH. Estes, NA, et al. Diagnosing Syncope. Part I: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med 1997;126(12):989-96. 3. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardilo 1992;20(6):1391-6. 4. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segement elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27(5):1061-70. 5. Alings M, Wilde A. "Brugada" Syndrome: clinical data and suggested pathophysilogica mechanism. Circulation 1999;99(5):666-73.

Shum et al./brugada syndrome 109 6. Antzelevitch C, Brugada P, Brugada J, et al. Clinical approaches to tachyarrhythmias: In: Camm AJ, ed. The 7. Hermida JS, Lemoine JL, Aoun FB, et al. Prevalence of the brugada syndrome in an apparently healthy population. Am J Cardiol 2000;86(1):91-4. 8. Tohyou Y, Nakazawa K, Takenobu H, et al. A survey in the incidence of RBBB with ST elevation among normal population. Jpn J Electrocardiol 1995;15:223-6. 9. Anzelevitch C. The Brugada syndrome. J Cardiovasc Electrophysiol 1998:9(5):513-6. 10. Mok NS, Chan KK, Chung HK, et al. Characteristics of Local Chinese patients who demonstrated Brugada pattern of Electrocardiogram in right precordial leads. J HK Coll Cardiol 2000;8:76. 11. Mok NS, Chan NY, Wong TY, et al. Brugada syndrome in two local Chinese men. J HK Coll Cardiol 2000;8: 15-21. 12. Atarashi H, Ogawa S, Harumi K, et al. Characteristics of patients with right bundle branch block and STsegment elevation in right precordial leads. Idiopathic Ventricular Fibrillation Investigation. Am J Cardiol 1996;78(5):581-3.